This announcement is a separate document:
国浩律师（上海）事务所关于上海复星医药（集团）股份有限公司2022年限制性A股股票激励计划部分限制性股票回购注销实施情况的法律意见书
Legal Opinion of Law Guohao (Shanghai) Firm on the implementation of some restricted stock repurchase cancellations in the 2022 restricted A-share stock incentive plan of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.